SCVC is an award-winning deep tech venture capital firm based in Bristol, UK, led by exited founders with deep technical expertise. It invests in early-stage UK deep tech startups — from pre-seed to Series A — across areas including biotech, quantum, AI, and advanced materials.
47% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (40% of deals). Average disclosed round size is $27.6M (across 5 rounds with reported amounts).
Portfolio
13
Fund Size
$100M
Top Stage
Seed
Last 12 Mo
1
Team
HD
Harry Destecroix
Managing Partner
CF
Catherine Fletcher
General Partner
JW
John Williams
General Partner
LD
Laura Davies
Deep Tech Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Houdini Bio | Pre-Seed | $1.9M | Jun 2026 |
| SScarlet Therapeutics | Seed | — | Jan 2026 |
 Portal Biotech | Series A | $35M | Jun 2025 |
| Portal Biotech | Series A | — | Jan 2025 |
| IIsomab | Seed | — | Feb 2024 |
| IInmagene | Series B | $21M | Nov 2020 |
| Houdini Bio | Pre-Seed | — | — |
| DDelta g Ltd | Seed | — | — |
 Phovir | Seed | — | — |
 IsomAb | Seed | — | — |
| MMedusa Materials | Unknown | — | — |
 Nebu Flow | Growth | $5.9M | — |
 EpimAb Biotherapeutics | Series B | $74M | — |
 Scarlet | Seed | — | — |
 Zero Point Motion | Series A | — | — |
Top Co-Investors
8VC2 shared
WS Investment Company2 shared
Earlybird Venture Capital2 shared
We Venture Capital2 shared
Amino Collective2 shared
British Business Bank2 shared
Pillar VC2 shared
Cambridge Enterprise2 shared
Deep Science Ventures2 shared
Broadview Ventures2 shared
Eos Advisory2 shared
Innovation Nest1 shared
XYZ Venture Capital1 shared
Panacea Venture1 shared
Northern Gritstone1 shared
Ascension Ventures1 shared
Sherpa Healthcare Partners1 shared
Decheng Capital1 shared
Entrepreneurs First1 shared
Last updated: 20 October 2026